Skip to main content
AAN.com

Abstract

Background and Objectives

Gynecologic diseases such as uterine fibroids, endometriosis, and adenomyosis are common in women of reproductive age. Case reports and small case series have reported ischemic stroke in women with such common noncancerous gynecologic diseases, and their cause of stroke is frequently attributed to cryptogenic stroke or unconventional mechanisms related to hypercoagulability. However, stroke etiology and prognosis are not well known. We assessed the prevalence of and stroke mechanisms related to common noncancerous gynecologic diseases using hospital-based clinical data.

Methods

We retrospectively identified consecutive female patients with common noncancerous gynecologic diseases (uterine fibroids, endometriosis, and adenomyosis) diagnosed with ischemic stroke/transient ischemic attack (TIA) between the ages of 20 and 59 years admitted to 10 stroke centers in Japan by reviewing prospectively collected data between 2017 and 2019. The clinical, laboratory, and neuroimaging features were evaluated and compared between patients with conventional stroke mechanisms (CSMs) (large artery atherosclerosis, small vessel occlusion, cardioembolism, and other determined etiology) and non-CSMs (cryptogenic stroke and causes related to hypercoagulability such as nonbacterial thrombotic endocarditis and paradoxical embolism) according to the Trial of Org 10172 in Acute Stroke Treatment criteria.

Results

Of the 470 female patients with ischemic stroke/TIA, 39 (8%) (37 ischemic stroke and 2 TIA) had common noncancerous gynecologic diseases. The most common gynecologic diseases were uterine fibroids in 24 (62%) patients, followed by endometriosis in 9 (23%) and adenomyosis in 6 (15%). Twenty patients (51%) were assigned to the non-CSMs group, and 19 patients (49%) were assigned to the CSMs group. Adenomyosis and endometriosis were more frequent in the non-CSMs group than in the CSMs group. CA125 and D-dimer levels were higher in the non-CSMs group than in the CSMs group. Multiple vascular territory infarcts were frequent in patients with adenomyosis (60%) and endometriosis (43%) in the non-CSMs group. No stroke recurrence or death was observed within 3 months after discharge in both the CSMs and non-CSMs groups. Outcomes at 3 months after discharge were similar in both groups.

Discussion

In patients with common noncancerous gynecologic diseases, hypercoagulopathy may play a role in the pathogenesis of ischemic stroke/TIA without CSMs.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Stewart EA. Uterine fibroids. N Engl J Med. 2015;372(17):1646-1655. doi.
2.
Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Vigano P. Endometriosis. Nat Rev Dis Primers. 2018;4(1):9. doi.
3.
Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020;26(3):392-411. doi.
4.
Yamashiro K, Tanaka R, Nishioka K, et al. Cerebral infarcts associated with adenomyosis among middle-aged women. J Stroke Cerebrovasc Dis. 2012;21(8):910.e1-910.e5. doi.
5.
Soeda S, Mathuda N, Hashimoto Y, Yamada H, Fujimori K. Non-bacterial thrombotic endocarditis with systemic embolic events caused by adenomyosis. J Obstet Gynaecol Res. 2011;37(12):1838-1841. doi.
6.
Tadokoro Y, Sakaguchi M, Yagita Y, et al. Ischemic stroke in patients with solid gynecologic tract tumors and coagulopathy. Eur Neurol. 2013;70(5-6):304-307. doi.
7.
Uchino K, Shimizu T, Mizukami H, et al. Nonbacterial thrombotic endocarditis complicated by cerebral infarction in a patient with adenomyosis with high serum CA125 level; a case report. J Stroke Cerebrovasc Dis. 2018;27(3):e42-e45. doi.
8.
Srivatsa A, Burdett J, Gill D. A 35-year-old woman with uterine fibroids and multiple embolic strokes. Neurology. 2005;64(8):1479-1480. doi.
9.
Kim JH, Koo J, Lee K. Simultaneously occurring ischemic stroke, leg artery occlusion, and pulmonary embolism induced by a uterine myoma. J Stroke Cerebrovasc Dis. 2022;31(4):106328. doi.
10.
Higuchi E, Toi S, Shirai Y, et al. Recurrent cerebral infarction due to benign uterine myoma. J Stroke Cerebrovasc Dis. 2019;28(1):e1-e2. doi.
11.
Bang OY, Chung JW, Lee MJ, Seo WK, Kim GM, Ahn MJ. Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms. J Stroke. 2020;22:1-10. doi.
12.
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41. doi.
13.
Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018;17(9):790-801. doi.
14.
Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001;276(29):27371-27375. doi.
15.
Shao B, Wahrenbrock MG, Yao L, et al. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood. 2011;118(15):4015-4023. doi.
16.
Robitaille Y. Hemorrhagic infarcts caused by mucin emboli mimicking brain purpura. Cancer. 1980;46(7):1608-1611. doi.
17.
Amico L, Caplan LR, Thomas C. Cerebrovascular complications of mucinous cancers. Neurology. 1989;39(4):522-526. doi.
18.
Jovin TG, Boosupalli V, Zivkovic SA, Wechsler LR, Gebel JM. High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer. Neurology. 2005;64(11):1944-1945. doi.
19.
Kil K, Chung JE, Pak HJ, et al. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma. Eur J Obstet Gynecol Reprod Biol. 2015;185:131-135. doi.
20.
Barbieri RL, Niloff JM, Bast RC Jr, Schaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril. 1986;45(5):630-634. doi.
21.
Babacan A, Kizilaslan C, Gun I, Muhcu M, Mungen E, Atay VCA. CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics. Int J Clin Exp Med. 2014;7(4):1078-1083.
22.
Yamashiro K, Furuya T, Noda K, Urabe T, Hattori N, Okuma Y. Cerebral infarction developing in a patient without cancer with a markedly elevated level of mucinous tumor marker. J Stroke Cerebrovasc Dis. 2012;21(7):619.e1-619.e2. doi.
23.
Hijikata N, Sakamoto Y, Nito C, et al. Multiple cerebral infarctions in a patient with adenomyosis on hormone replacement therapy: a case report. J Stroke Cerebrovasc Dis. 2016;25(10):e183-e184. doi.
24.
Kim B, Kim SH, Kim T. Cerebral infarcts by nonbacterial thrombotic endocarditis associated with adenomyosis: a case report. J Stroke Cerebrovasc Dis. 2018;27(3):e50-e53. doi.
25.
Aso Y, Chikazawa R, Kimura Y, Kimura N, Matsubara E. Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report. BMC Neurol. 2018;18(1):119. doi.
26.
Okazaki K, Oka F, Ishihara H, Suzuki M. Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases. BMC Neurol. 2018;18(1):166. doi.
27.
Yin X, Wu J, Song S, Zhang B, Chen Y. Cerebral infarcts associated with adenomyosis: a rare risk factor for stroke in middle-aged women: a case series. BMC Neurol. 2018;18(1):213. doi.
28.
Zhao Y, Zhang Y, Yang Y. Acute cerebral infarction with adenomyosis in a patient with fever: a case report. BMC Neurol. 2020;20(1):210. doi.
29.
Aiura R, Nakayama S, Yamaga H, Kato Y, Fujishima H. Systemic thromboembolism including multiple cerebral infarctions with middle cerebral artery occlusion caused by the progression of adenomyosis with benign gynecological tumor: a case report. BMC Neurol. 2021;21(1):14. doi.
30.
Yasuda M, Yamanaka Y, Kano H, et al. Recurrent cerebral infarcts associated with uterine adenomyosis: successful prevention by surgical removal. Intern Med. 2022;61(5):735-738. doi.
31.
Arai N, Yachi K, Ishihara R, Fukushima T. Adenomyosis-associated recurrent acute cerebral infarction mimicking Trousseau's syndrome: a case study and review of literature. Surg Neurol Int. 2022;13:179. doi.
32.
Sheth SS, Ray SS. Severe adenomyosis and CA125. J Obstet Gynaecol. 2014;34(1):79-81. doi.
33.
Liu X, Nie J, Guo SW. Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis. Hum Reprod. 2011;26(2):337-345. doi.
34.
Nakamura Y, Kawamura N, Ishiko O, Ogita S. Acute disseminated intravascular coagulation developed during menstruation in an adenomyosis patient. Arch Gynecol Obstet. 2002;267(2):110-112. doi.
35.
Yamanaka A, Kimura F, Yoshida T, et al. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia. Eur J Obstet Gynecol Reprod Biol. 2016;204:99-103. doi.
36.
Navi BB, Kasner SE, Elkind MSV, Cushman M, Bang OY, DeAngelis LM. Cancer and embolic stroke of undetermined source. Stroke. 2021;52(3):1121-1130. doi.
37.
Sondergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic Stroke. N Engl J Med. 2017;377(11):1033-1042. doi.
38.
Toru S, Murata T, Ohara M, Ishiguro T, Kobayashi T. Paradoxical cerebral embolism with patent foramen ovale and deep venous thrombosis caused by a massive myoma uteri. Clin Neurol Neurosurg. 2013;115(6):760-761. doi.
39.
Morales Vidal S, Verma G, Goldschmidt C, Biller J. Stroke due to paradoxical embolization related to fibroid uterus enlargement compressing the right common iliac vein. Case Rep Neurol. 2018;10(3):328-331. doi.
40.
Naito H, Naka H, Kanaya Y, Yamazaki Y, Tokinobu H. Two cases of acute ischemic stroke associated with iron deficiency anemia due to bleeding from uterine fibroids in middle-aged women. Intern Med. 2014;53(21):2533-2537. doi.
41.
Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;67(10):640-641. doi.
42.
Bushnell CD. Oestrogen and stroke in women: assessment of risk. Lancet Neurol. 2005;4(11):743-751. doi.
43.
Correia P, Machado S, Meyer I, Amiguet M, Eskandari A, Michel P. Ischemic stroke on hormonal contraceptives: characteristics, mechanisms and outcome. Eur Stroke J. 2021;6(2):205-212. doi.
44.
Okoth K, Wang J, Zemedikun D, Thomas GN, Nirantharakumar K, Adderley NJ. Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study. BJOG. 2021;128(10):1598-1609. doi.
45.
Nakajima S, Kawano H, Yamashiro K, et al. Post-treatment plasma D-dimer levels are associated with short-term outcomes in patients with cancer-associated stroke. Front Neurol. 2022;13:868137. doi.
46.
Mojadidi MK, Zaman MO, Elgendy IY, et al. Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol. 2018;71(9):1035-1043. doi.
47.
Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478-2486. doi.

Information & Authors

Information

Published In

Neurology® Clinical Practice
Volume 13Number 3June 2023

Publication History

Received: August 1, 2022
Accepted: March 10, 2023
Published online: April 27, 2023
Published in print: June 2023

Permissions

Request permissions for this article.

Disclosure

The authors report no disclosures relevant to the manuscript. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.
Take-home Points
→ Among female patients with ischemic stroke/TIA, 8% had common noncancerous gynecologic diseases, such as uterine fibroids, endometriosis, and adenomyosis.
→ Half of the patients with ischemic stroke/TIA and common noncancerous gynecologic diseases had non-CSMs that included cryptogenic stroke, NBTE, and paradoxical embolism.
→ Patients with non-CSMs had higher frequencies of adenomyosis and endometriosis, and higher CA125 and D-dimer levels than those with CSMs.
→ Hypercoagulopathy may play a role in the pathogenesis of ischemic stroke/TIA in patients with common noncancerous gynecologic diseases and non-CSMs.

Study Funding

The authors report no targeted funding.

Authors

Affiliations & Disclosures

Kazuo Yamashiro, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Takeo Sato, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Chikako Nito, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Kaneka Corp.
Research Support, Government Entities:
1.
JSPS KAKENHI Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, #21K09163, Lead investigator, 2021-2024
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Hiroyuki Kawano, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Tetsuya Chiba, MD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Takahito Nishihira, MD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Takafumi Mizuno, MD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kentaro Ishizuka, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Yasuyuki Iguchi, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
1) Journal name; Neurosonology, Role; Chief editor, Year; 3 years
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
1) Otsuka Co. $4,000, 2018, 2) Daiichisankyo Co. $8,000, 2018, 3) Takeda Co. $4,000, 2018, 4) Sanofi Co. $1,000, 2018, 5) Boehringer Ingelheim GmbH, $4,000, 2018, 6) Pfizer Inc. $3,000, 2018, 7) Bayer AG, $3,000, 2018, 8)Otsuka Co. $3,000, 2017, 9) Daiichisankyo Co. $9,400, 2017, 10) Takeda Co. $5,000, 2017, 11) Boehringer Ingelheim GmbH, $5,000, 2017, 12) Bayer AG, $3,000, 2017, 13) Pfizer Inc. $3,000, 2017, 14) Sanofi Co. $1,000, 2017
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
1) Otsuka Co. $9,300, 2018, 2) Daiichisankyo Co. $9,300, 2018, 3) Takeda Co. $9,300, 2018, 4) Sanofi Co. $18,600, 2018, 5)Otsuka Co. $9,300, 2017, 6) Daiichisankyo Co. $9,300, 2017, 7) Takeda Co. $14,000, 2017, 8) Boehringer Ingelheim GmbH, $9,300, 2017, 9) Bayer AG, $9,300, 2017, 10) Astellas Pharma Inc, $9,300, 2017
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kazumi Kimura, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Kazumi Kimura received lecture fees from Bristol-Myers Squibb Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Bayer Healthcare Co. Ltd., and Daiichi Sankyo Co.; research funding from Nippon Boehringer Ingelheim Co. Ltd., Daiichi Sankyo Co., Pfizer Japan Inc., Medtronic Co. Ltd., and Teijin Pharma Ltd.
Editorial Boards:
1.
European Neurology
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kazuo Kitagawa, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
(1) Journal of Atherosclerosis and Thrombosis, Associate editor
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
(1) Kyowa Kirin (2) Daiichi-Sankyo
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
(1) Clinical procedure (Neurology and Stroke Center), 50% of effort
Research Support, Commercial Entities:
1.
(1) Daiichi-Sankyo (2) Eisai (3) Boehringer Ingelheim (4) Dainippon Sumitomo
Research Support, Government Entities:
1.
(1) Grants-in-Aid for Scientific Researchin Japan (C), 19K07968, cheif investigator, 2019-2021
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
An editorial board member, Cerebrovascular DiseasesAn editorial board member, Journal of Atherosclerosis and ThrombosisAn editorial board member, Rinsho Shinkeigaku (Clin Neurol) An associate editor, Japanese Journal of Stroke
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
(1) Bayer Yakuhin (2) Daiichi-Sankyo (3) Mitsubishi Tanabe Pharma Corporation
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1)Research support from Daiichi-Sankyo, (2) Research Support from Shionogi, (3) Research support from Nippon Boeringer Ingelheim
Research Support, Government Entities:
1.
(1)Research funding from Japan Agency for Medical Research and Development, 20ek0210139h0001, PI, 2 years
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Teruyuki Hirano, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Bayer, lecture's fee(2) Daiichi-Sankyo, lecture's fee(3) Pfyzer, lecture's fee
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
(1) Grant-in-Aid for Scientific Research, Lead investigator, 19K07980
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Tomoaki Kameda, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Hidehiro Takekawa, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
Journal of Medical Ultrasonics, Associate Editor, 4 yearsNeurosonology, Editor-in-chief, 1 year
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Takao Urabe, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Akiyo Taneichi, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Hiroyuki Fujiwara, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Shigeru Fujimoto, MD, PhD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Daiichi-Sankyo, lecture fee(2) Bristol Myers Squib, lecture fee
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Nobutaka Hattori, MD, PHD
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
Movement Disorders-Clinical Practice, Journal of Neural Transmission, Neuroscience Research, JNNP, J of Parkinson's disease
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Hisamitsu Pharmaceutical, Dai-Nippon Sumitomo Pharma Co.,Ltd., Kyowa Hakko Kirin,
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Department of Neurology (KY, YU, NH, RT), Juntendo University School of Medicine, Tokyo; Department of Neurology (KY, TU), Juntendo University Urayasu Hospital, Chiba; Department of Neurology (TS, YI), Jikei University School of Medicine, Tokyo; Department of Neurology (CN, Kazumi Kimura), Nippon Medical School, Tokyo; Department of Neurology (YU), University of Yamanashi; Department of Stroke and Cerebrovascular Medicine (HK, TH), Kyorin University, Tokyo; Department of Cerebrovascular Medicine (TC, MK), National Cerebral and Cardiovascular Center, Suita; Stroke Center (TN, HT), Dokkyo Medical University, Tochigi; Department of Neurology (TM, KI, Kazuo Kitagawa), Tokyo Women's Medical University, Tokyo; Department of Neurology (TK), Shin-Oyama City Hospital, Tochigi; Department of Obstetrics and Gynaecology (AT, HF), Jichi Medical University, Tochigi; and Division of Neurology (SF, RT), Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
R.T. received honoraria for work unrelated to this study from Takeda Pharmaceutical Co.,Ltd., Nippon Boehringer Ingelheim,Co.,Ltd, Dai-Nippon Sumitomo Pharma Co.,Ltd., Bayer Yakuhin, Ltd, Otsuka Pharmaceutical, Co.,Ltd, Pfizer Japan Inc., DAIICHI SANKYO Co.,Ltd., Eisai Co.,Ltd., Bristol-Myers Squibb Co., Stryker Japan K.K., CSL Behring K.K,. and Kowa Co.,Ltd.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Tanaka [email protected]
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.
Submitted and externally peer reviewed. The handling editor was Associate Editor Amanda Jagolino-Cole, MD, FAAN.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Causal relationship between uterine fibroids and cardiovascular disease: A two-sample Mendelian randomization study, Medicine, 104, 9, (e41713), (2025).https://doi.org/10.1097/MD.0000000000041713
    Crossref
  2. Recurrent ischemic strokes and elevated CA125 levels in a patient with Meigs syndrome: A case report , Neurology and Clinical Neuroscience, 13, 1, (63-65), (2024).https://doi.org/10.1111/ncn3.12843
    Crossref
  3. Pulmonary embolism after diagnostic curettage in patient with adenomyosis and hysteromyoma: A case report and brief review of literature, Medicine, 102, 48, (e36279), (2023).https://doi.org/10.1097/MD.0000000000036279
    Crossref
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share